C4 Therapeutics (NASDAQ:CCCC) Given New $5.00 Price Target at Bank of America
C4 Therapeutics (NASDAQ:CCCC – Get Rating) had its target price cut by Bank of America from $11.00 to $5.00 in a report issued on Tuesday morning, The Fly reports. They currently have a neutral rating on the stock. A number of other research firms have also weighed in on CCCC. Morgan Stanley dropped their price […]